North America Transfection Reagents and Equipment market size was approximately USD 214.62 million in 2016. It is estimated to grow at a CAGR of 7.6 % to reach USD 309.55 million by 2021.
It is the largest market globally capturing a market share of 30%.
Process which involve the insertion of genetic material, for example, DNA and RNA (double stranded), into mammalian cells is called as transfection. Substances containing the genetic material are called transfection reagents and the equipment is usually used as a delivery mechanism.
View Full Report: marketdataforecast.com/market-repo…ment-market-3218/
Technological advancements occurring in the transfection reagents and equipment market in the recent years has addressed the needs of researchers along with biotechnology & biopharmaceutical companies.
High efficiency transfection instruments have entered the market because of these advancements. Further, efficient quantitative and qualitative transfection in a wide range of cells, encompassing the hard-to-transfect cells are also the result of the technological advances.
Alliances worldwide between the pioneering research institutes to trigger drug discovery, technological advancements in transfections, research activities by pharmaceutical and biotechnology companies coupled with augmented research and development spending, increasing number of cases of cancer and rise in demand for synthetic genes are driving the growth of this market.
Home brew reagents by researchers, selective effectiveness of transfection reagents as well as the hefty costs of transfection reagents are the primary factors expected to slow down the growth of this market.
On the basis of product, Transfection Reagents and Equipment market is classified into Reagents and Instruments. In 2016, the reagents category is projected to account for the biggest market share.
Although, the instruments market is probably grow at the highest CAGR during the aforementioned forecast period. If we go by gimmick, Transfection Reagents and Equipment market is segmented into Biochemical, Calcium Phosphate, Lipofection, DEAE-dextran, Dendrimers, Physical, Electroporation, Nucleofection, Others and Viral.
In 2016, the biochemical category is projected to command the largest market share, whereas the viral category is estimated to grow at the highest CAGR during the aforementioned forecast period. Further, on the basis of application the market can be categorized into Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production and Therapeutic Delivery.
In 2016, the biomedical research category is likely to command the largest market share. Last but not the least, on the basis of end user the market is segmented into Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
In 2016, the academic & research institutes category is likely to command the largest market share. Although, the pharmaceutical & biotechnologies category is estimated to grow at the highest CAGR during the aforementioned forecast period.
By geography, the North America Transfection Reagents and Equipment market has been categorized into US and Canada. Presently, North America accounts for the largest market share.
US is the leading market in North America.
Major companies in the Transfection Reagents and Equipment market are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd.
(Switzerland), and QIAGEN N.V. (Netherlands). These companies hold a leading position in the transfection reagent and equipment market because of their well-established presence in the fields of genomics, spanning fifty countries, heavy R&D investments, and strong sales as well as distribution force.
Other players in the market include Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!